#AddictionMedicine #GLP1 #RecoveryScience #PublicHealth #CaronTreatmentCenters #CASPR #SteveKleinMD To view or add a comment, sign in American Osteopathic Academy of Addiction Medicine - AOAAM and Opioid Response Network Fall 2025 Presentation Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-experimental Comparison Presented by: Anjalee Sharma, PhD Assistant Research Scientist at Friends Research Institute, Baltimore, MD As illicitly manufactured fentanyl has largely replaced heroin in the U.S., its withdrawal characteristics remain insufficiently understood
The future of Semaglutide research holds promise for optimizing its use and minimizing side effects
See CJC-1295 + Ipamorelin Blend vs Separate Vials for the formulation research-design logic
Lingvay I, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, et al